ArticleHistory and philosophy of the life sciences2021
Aging biomarkers and the measurement of health and risk.
Article in History and philosophy of the life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 35 citations in OpenAlex.
- Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases.Probiotics and antimicrobial proteins · 2026Review
- Evolution of joint power across the lifespan during walking.Journal of neuroengineering and rehabilitation · 2025Article
- Revealing the Spatial Pattern of Brain Hemodynamic Sensitivity to Healthy Aging through Sparse Dynamic Causal Model.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025Article
- Impact of Mind-Body Interventions on Psychosocial and Bio Physiological Markers among Elderly.Journal of pharmacy & bioallied sciences · 2024Article
- Ethics of early detection of disease risk factors: A scoping review.BMC medical ethics · 2024Article
- Progress in the study of aging marker criteria in human populations.Frontiers in public health · 2024Review
- Association of Exposure to Indoor Air Pollution with Unhealthy Symptoms among Middle-aged and Older Adults in India: Evidence from a Large-scale Survey.Environmental health insights · 2024Article
- Early aging and premature vascular aging in chronic kidney disease.Clinical kidney journal · 2023Review
- The Potential Role of C-Reactive Protein in Metabolic-Dysfunction-Associated Fatty Liver Disease and Aging.Biomedicines · 2023Review
- Challenges facing the clinical adoption of a new prognostic biomarker: a case study.BioSocieties · 2023Article
- Slowing down decay: biological clocks in personalized medicine.Frontiers in sociology · 2023Article
- Medawar and Hamilton on the selective forces in the evolution of ageing.History and philosophy of the life sciences · 2021Article
- Rethinking ageing: introduction.History and philosophy of the life sciences · 2021Article
- Metabolically Unhealthy Phenotype: A Key Factor in Determining "Pediatric" Frailty.Pediatric reports · 2021Article
- The plasticity of ageing and the rediscovery of ground-state prevention.History and philosophy of the life sciences · 2021Article
- What's my age again? Age categories as interactive kinds.History and philosophy of the life sciences · 2021Article
- Does anybody really know what time it is? : From biological age to biological time.History and philosophy of the life sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Prevention of age-related disorders is increasingly in focus of health policies, and it is hoped that early intervention on processes of deterioration can promote healthier and longer lives. New opportunities to slow down the aging process are emerging with new fields such as personalized nutrition. Data-intensive research has the potential to improve the precision of existing risk factors, e.g., to replace coarse-grained markers such as blood cholesterol with more detailed multivariate biomarkers. In this paper, we follow an attempt to develop a new aging biomarker. The vision among the project consortium, comprising both research and industrial partners, is that the new biomarker will be predictive of a range of age-related conditions, which may be preventable through personalized nutrition. We combine philosophical analysis and ethnographic fieldwork to explore the possibilities and challenges of managing aging through bodily signs that are not straightforwardly linked to symptomatic disease. We document how the improvement of measurement brings about new conceptual challenges of demarcating healthy and unhealthy states. Moreover, we highlight that the reframing of aging as risk has social and ethical implications, as it is generative of normative notions of what constitutes successful aging and good citizenship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.